Zerodha founder Nithin Kamath in a Twitter thread warned that the issued ESOPs of many companies over the last few years will be out of money. He also spoke about the fall in share prices of high growth tech companies globally.

Major pharma stocks have declined in the recent past. Analysts say the fading increase in sales on account of the pandemic and high regulation is keeping the pharma space from enjoying the kind of gains enjoyed by other exporters.

Stock Market Highlights: Indian equity benchmarks BSE Sensex and NSE Nifty50 failed to hold on to the green in a volatile session on Tuesday, Indian equity benchmarks failed to hold on to the green in volatile trade on Tuesday, dragged by oil & gas, metal and IT shares though gains in select financial and FMCG shares lent some support. Broader markets suffered deeper cuts, with the Nifty Midcap 100 and Nifty Smallcap 100 indices falling around two percent each. Globally, concerns about aggressive hikes in COVID-era interest rates and the prospect of falling world economic growth kept investors nervous. 

With Gujarat Narmada Valley Fertilizers and Chemicals Ltd (GNFC) and UPL Ltd reporting robust numbers for the quarter ended March 2022, market experts believe there are some decent investment opportunities in the chemicals and fertiliser space.